Arkolith/Insider Trading/ASND/Form 4

Bienaime Jean Jacques

DirectorAscendis Pharma A/S (ASND) · full profile →Form 4 · filed May 27, 2026
Net Buying
Open-Market Buys
$95K
Open-Market Sells
$0
Net Open-Market Flow
$95K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2026Buy(P)200$236.24$47K200
May 26, 2026Buy(P)200$239.37$48K400

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000161) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML